Oral Glucocorticoid Use and Osteonecrosis in Chronic Inflammatory Diseases: A Population‐based Cohort Study

Sep-15

AUTHORS : Dr Daniel B. Horton, Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, 112 Paterson St, New Brunswick, NJ 08901, USA – Email: daniel.horton@rutgers.edu – Profile: https://pets.rutgers.edu/people/daniel-horton/ – see study 10.1136/bmjopen-2017-016788, Dr Horton now at Rutgers Center for Pharmacoepidemiology and Treatment Science

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 24(S1):215-216

DOI : 10.1002/pds.3838

Oral Glucocorticoid Use and Osteonecrosis in Chronic Inflammatory Diseases: A Population‐based Cohort Study

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study